Loss of NF2 defines a genetic subgroup of non‐FOS‐rearranged osteoblastoma

Osteoblastoma is a locally aggressive tumour of bone. Until recently, its underlying genetic features were largely unknown. During the past two years, reports have demonstrated that acquired structural variations affect the transcription factor FOS in a high proportion of cases. These rearrangements...

Descripción completa

Detalles Bibliográficos
Autores principales: Saba, Karim H, Cornmark, Louise, Hofvander, Jakob, Magnusson, Linda, Nilsson, Jenny, van den Bos, Hilda, Spierings, Diana CJ, Foijer, Floris, Staaf, Johan, Brosjö, Otte, Sumathi, Vaiyapuri P, Lam, Suk Wai, Szuhai, Karoly, Bovée, Judith VMG, Kovac, Michal, Baumhoer, Daniel, Styring, Emelie, Nord, Karolin H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578308/
https://www.ncbi.nlm.nih.gov/pubmed/32542935
http://dx.doi.org/10.1002/cjp2.172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578308/
https://www.ncbi.nlm.nih.gov/pubmed/32542935
http://dx.doi.org/10.1002/cjp2.172

Ejemplares similares